期刊
CELL REPORTS
卷 17, 期 2, 页码 366-373出版社
CELL PRESS
DOI: 10.1016/j.celrep.2016.09.022
关键词
-
类别
资金
- National Cancer Institute of the NIH [5RO1CA172023, 5RO1CA190477, 5RO1CA085533, RO1GM105933, RO1GM115961]
Although previous studies indicate that loss of p53-mediated cell cycle arrest, apoptosis, and senescence does not completely abrogate its tumor suppression function, it is unclear how the remaining activities of p53 are regulated. Here, we have identified an acetylation site at lysine K98 in mouse p53 (or K101 for human p53). Whereas the loss of K98 acetylation (p53(K98R)) alone has very modest effects on p53-mediated transactivation, simultaneous mutations at all four acetylation sites (p53(4KR): K98R+ 3KR[K117R+K161R+K162R]) completely abolish its ability to regulate metabolic targets, such as TIGAR and SLC7A11. Notably, in contrast to p53(3KR), p53(4KR) is severely defective in suppressing tumor growth in mouse xenograft models. Moreover, p53(4KR) is still capable of inducing the p53-Mdm2 feedback loop, but p53-dependent ferroptotic responses are markedly abrogated. Together, these data indicate the critical role of p53 acetylation in ferroptotic responses and its remaining tumor suppression activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据